Showing results (161-170 of 239) with videos related to
Sort By:
Pageof 24
Journal of Hepatology|April 12, 2020
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statementMohammed Eslam, Philip N Newsome, Shiv K Sarin, et al.Liver International : Official Journal of the International Association for the Study of the Liver|April 23, 2016
The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver diseaseKonstantin Kazankov, Francisco Barrera, Holger Jon Møller, et al.Hepatic Oncology|June 4, 2021
Endotrophin, a pro-peptide of Type VI collagen, is a biomarker of survival in cirrhotic patients with hepatocellular carcinomaDiana Julie Leeming, Signe Holm Nielsen, Roslyn Vongsuvanh, et al.Cancer Letters|December 22, 2020
An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cellsGang Zhou, Sarah Da Won Bae, Romario Nguyen, et al.Journal of Hepatocellular Carcinoma|November 18, 2020
Cross-Linked Multimeric Pro-Peptides of Type III Collagen (PC3X) in Hepatocellular Carcinoma - A Biomarker That Provides Additional Prognostic Value in AFP Positive PatientsChristina Jensen, Signe Holm Nielsen, Mohammed Eslam, et al.Metabolism: Clinical and Experimental|September 27, 2023
Circulating hormones in biopsy-proven steatotic liver disease and steatohepatitis: A Multicenter Observational StudyLaura Valenzuela-Vallejo, Pavlina Chrysafi, Matina Kouvari, et al.Science Translational Medicine|April 3, 2024
Inhibition of MERTK reduces organ fibrosis in mouse models of fibrotic diseaseZiyan Pan, Rasha El Sharkway, Ali Bayoumi, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 12, 2020
Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Nonalcoholic Steatohepatitis-Related, Child-Pugh A CirrhosisEduardo Vilar-Gomez, Luis Calzadilla-Bertot, Vincent Wai-Sun Wong, et al.Annals of Hepatology|July 2, 2013
Predicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variablesMohammed Eslam, Javier Ampuero, Maria Jover, et al.Liver Cancer|March 6, 2023
Discriminatory Changes in Circulating Metabolites as a Predictor of Hepatocellular Cancer in Patients with Metabolic (Dysfunction) Associated Fatty Liver DiseaseHaonan Lu, Jacob George, Mohammed Eslam, et al.Pageof 24